Clinical trials show that patients on tirzepatide typically reduce daily calorie intake by 5001,500 calories naturally, without conscious restriction, because the medication signals fullness to your brain more effectively
Tirzepatide is a dual GLP-1/GIP receptor agonist the medication behind FDA-approved brands Zepbound (chronic weight management) and Mounjaro (type 2 diabetes)
A randomized, double-blind, placebo-controlled, crossover study investigated the effects of liraglutide 1.8 and 3.0 mg for 5 weeks in obese non-diabetic patients
Alpha Lipoic Acid - anti-oxidant that boosts glutathione levels in cells
When urine travels along the strip, hCG binds to these antibodies, triggering a colored line
Studies show that most people regain weight after stopping these medications, as their appetite returns